{"id":"https://openalex.org/W1599717293","doi":"https://doi.org/10.1046/j.1432-1033.2002.03133.x","title":"A peptide derived from cyclin\u2010dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells","display_name":"A peptide derived from cyclin\u2010dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells","alternate_titles":[],"publication_year":2002,"publication_date":"2002-09-01","ids":{"openalex":"https://openalex.org/W1599717293","doi":"https://doi.org/10.1046/j.1432-1033.2002.03133.x","mag":"1599717293","pmid":"https://pubmed.ncbi.nlm.nih.gov/12230554"},"language":"en","primary_location":{"id":"doi:10.1046/j.1432-1033.2002.03133.x","doi":"https://doi.org/10.1046/j.1432-1033.2002.03133.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1432-1033.2002.03133.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1432-1033.2002.03133.x","source":{"id":"https://openalex.org/S4210214924","display_name":"European Journal of Biochemistry","issn_l":"0014-2956","issn":["0014-2956","0945-5795","1432-1033"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Biochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1599717293"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1432-1033.2002.03133.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Ya\u2010li Zheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ya\u2010li Zheng","raw_affiliation_strings":["Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda 20892, USA","Laboratory of Neurochemistry National Institute of Neurological Disorders and Stroke, National Institutes of Health Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"raw_affiliation_string":"Laboratory of Neurochemistry National Institute of Neurological Disorders and Stroke, National Institutes of Health Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Bing\u2010Sheng Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bing\u2010Sheng Li","raw_affiliation_strings":["Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090823444","display_name":"Niranjana D. Amin","orcid":"https://orcid.org/0000-0001-9616-8294","observed_orcids":["https://orcid.org/0000-0001-9616-8294"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Niranjana D. Amin","raw_affiliation_strings":["Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051882752","display_name":"Wayne Albers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wayne Albers","raw_affiliation_strings":["Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5106792117","display_name":"Harish C. Pant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Harish C. Pant","raw_affiliation_strings":["Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5804,"has_fulltext":true,"cited_by_count":96,"citation_normalized_percentile":{"value":0.54776643,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"269","issue":"18","first_page":"4427","last_page":"4434"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk5","display_name":"cyclin-dependent kinase 5","score":0.9559999704360962},{"id":"https://openalex.org/keywords/p35","display_name":"p35","score":0.8209999799728394},{"id":"https://openalex.org/keywords/p25","display_name":"p25","score":0.9039999842643738},{"id":"https://openalex.org/keywords/tau-phosphorylation","display_name":"tau phosphorylation","score":0.800000011920929},{"id":"https://openalex.org/keywords/tau-hyperphosphorylation","display_name":"tau hyperphosphorylation","score":0.9879999756813049},{"id":"https://openalex.org/keywords/kinase-inhibition","display_name":"kinase inhibition","score":0.7129999995231628},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8040000200271606},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.6769999861717224},{"id":"https://openalex.org/keywords/neuronal-cytoskeleton","display_name":"neuronal cytoskeleton","score":0.8199999928474426}],"concepts":[{"id":"https://openalex.org/C121738310","wikidata":"https://www.wikidata.org/wiki/Q18248262","display_name":"Cyclin-dependent kinase 5","level":5,"score":0.9800940752029419},{"id":"https://openalex.org/C88045685","wikidata":"https://www.wikidata.org/wiki/Q174576","display_name":"Activator (genetics)","level":3,"score":0.6820323467254639},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6054473519325256},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.6031463742256165},{"id":"https://openalex.org/C2778198054","wikidata":"https://www.wikidata.org/wiki/Q15195154","display_name":"Hyperphosphorylation","level":3,"score":0.5690272450447083},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5373254418373108},{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.5228655338287354},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.5096051692962646},{"id":"https://openalex.org/C2776414213","wikidata":"https://www.wikidata.org/wiki/Q183290","display_name":"Serine","level":3,"score":0.5084816217422485},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.476337730884552},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.4424678087234497},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4243360459804535},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.4202001392841339},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4087314009666443},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.40272262692451477},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2679533362388611},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.15275511145591736},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.14833995699882507},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09966203570365906}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016203","descriptor_name":"CDC2 Protein Kinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016875","descriptor_name":"tau Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018844","descriptor_name":"Cyclin-Dependent Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051360","descriptor_name":"Cyclin-Dependent Kinase 5","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1432-1033.2002.03133.x","doi":"https://doi.org/10.1046/j.1432-1033.2002.03133.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1432-1033.2002.03133.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1432-1033.2002.03133.x","source":{"id":"https://openalex.org/S4210214924","display_name":"European Journal of Biochemistry","issn_l":"0014-2956","issn":["0014-2956","0945-5795","1432-1033"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Biochemistry","raw_type":"journal-article"},{"id":"pmid:12230554","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12230554","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of biochemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1046/j.1432-1033.2002.03133.x","doi":"https://doi.org/10.1046/j.1432-1033.2002.03133.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1432-1033.2002.03133.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1432-1033.2002.03133.x","source":{"id":"https://openalex.org/S4210214924","display_name":"European Journal of Biochemistry","issn_l":"0014-2956","issn":["0014-2956","0945-5795","1432-1033"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Biochemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1599717293.pdf","grobid_xml":"https://content.openalex.org/works/W1599717293.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W14542710","https://openalex.org/W1485851925","https://openalex.org/W1503126591","https://openalex.org/W1563116834","https://openalex.org/W1593693427","https://openalex.org/W1766779621","https://openalex.org/W1849680308","https://openalex.org/W1884426449","https://openalex.org/W1914313496","https://openalex.org/W1971103841","https://openalex.org/W1971468364","https://openalex.org/W1977971438","https://openalex.org/W1990844649","https://openalex.org/W1990922641","https://openalex.org/W2014898742","https://openalex.org/W2015265007","https://openalex.org/W2022329592","https://openalex.org/W2033529907","https://openalex.org/W2038901745","https://openalex.org/W2048560678","https://openalex.org/W2048595114","https://openalex.org/W2053160247","https://openalex.org/W2063484221","https://openalex.org/W2064850712","https://openalex.org/W2072428985","https://openalex.org/W2085532055","https://openalex.org/W2085593164","https://openalex.org/W2100954321","https://openalex.org/W2112047897","https://openalex.org/W2115688283","https://openalex.org/W2117354631","https://openalex.org/W2118888416","https://openalex.org/W2132503351","https://openalex.org/W6677653402"],"related_works":["https://openalex.org/W1983475875","https://openalex.org/W1975232691","https://openalex.org/W2123533032","https://openalex.org/W2045374982","https://openalex.org/W4365135150","https://openalex.org/W2572434541","https://openalex.org/W1978276744","https://openalex.org/W2511171894","https://openalex.org/W3009383098"],"abstract_inverted_index":{"Cyclin-dependent":[0],"kinase-5":[1],"(Cdk5)":[2],"is":[3,112],"a":[4,57],"serine/threonine":[5],"kinase":[6,94],"activated":[7],"by":[8,28,131],"its":[9,14],"neuron-specific":[10],"activator,":[11],"p35,":[12,70],"or":[13],"truncated":[15],"form,":[16],"p25.":[17],"It":[18],"has":[19],"been":[20],"proposed":[21],"that":[22,56,99,118],"the":[23,37,83,100,127,136,154],"deregulation":[24],"of":[25,102,135,139,145,156],"Cdk5":[26,64,73,146],"activity":[27,74,125,147],"association":[29],"with":[30,82,108],"p25":[31,140],"in":[32,44,75,78,104],"human":[33],"brain":[34],"tissue":[35],"disrupts":[36],"neuronal":[38],"cytoskeleton":[39],"and":[40,77,85,110,126,142,159],"may":[41,148],"be":[42],"involved":[43],"neurodegenerative":[45],"diseases":[46],"such":[47],"as":[48],"Alzheimer's":[49,157],"disease.":[50],"In":[51],"this":[52],"study,":[53],"we":[54,97],"demonstrate":[55,98],"short":[58],"peptide":[59,84],"(amino":[60],"acid":[61],"residues":[62],"154-279;":[63],"inhibitory":[65],"peptide;":[66],"CIP),":[67],"derived":[68],"from":[69],"specifically":[71,120],"inhibits":[72,121],"vitro":[76],"HEK293":[79,105],"cells":[80],"cotransfected":[81,107],"Cdk5/p25,":[86],"but":[87],"had":[88],"no":[89],"effect":[90],"on":[91],"endogenous":[92],"cdc2":[93],"activity.":[95],"Moreover,":[96],"phosphorylation":[101],"tau":[103,128],"cells,":[106],"Cdk5/p25":[109,123],"CIP,":[111],"effectively":[113],"reduced.":[114],"These":[115],"results":[116],"suggest":[117],"CIP":[119,143],"both":[122],"complex":[124],"hyperphosphorylation":[129],"induced":[130],"Cdk5/p25.":[132],"The":[133],"elucidation":[134],"molecular":[137],"basis":[138],"activation":[141],"inhibition":[144],"provide":[149],"insight":[150],"into":[151],"mechanisms":[152],"underlying":[153],"pathology":[155],"disease":[158],"contribute":[160],"to":[161],"therapeutic":[162],"strategies.":[163]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1599717293","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
